Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Expression Of Hedgehog Pathway Mediator Gli2 Represents a Clinically Negative Prognostic Marker In Acute Myeloid Leukemia and Its Inhibitor GANT61 Exerts Anti-Leukemic Effects In Vitro

Jasmin Wellbrock, Ph.D., Julian M Koehler, Katharina Wagner, MD, Emily Latuske, M.Sc., Hauke Stamm, M.Sc., Eik Vettorazzi, M.Sc., Gabi Vohwinkel, M.Sc., Marianne Klokow, Roswitha Kuhling-Thees, Sonja Loges, MD, Ph.D, Michael Amling, MD, Carsten Bokemeyer, MD, Michael Heuser, MD, Juergen Krauter, MD, Walter Fiedler, MD

Blood (2013) 122 (21): 53.

https://doi.org/10.1182/blood.V122.21.53.53

Published: 2013

Journal Articles

Clinical Impact of TERT A1062T Mutations in Younger Patients with Acute Myeloblastic Leukemia

Katharina Wagner, MD, Anna Both, Frederik Damm, MD, Felicitas Thol, MD, Gudrun Göhring, MD, Michael Heuser, MD, Oliver G. Ottmann, MD, Michael Lübbert, MD, Mohammed Wattad, MD, Lothar Kanz, MD, Günther Schlimok, MD, Aruna Raghavachar, MD, Walter Fiedler, MD, Hartmut Kirchner, MD, Wolfram Brugger, MD, Brigitte Schlegelberger, Gerhard Heil, MD, Arnold Ganser, Jürgen Krauter, Prof. Dr. med.

Blood (2012) 120 (21): 1381.

https://doi.org/10.1182/blood.V120.21.1381.1381

Published: 2012

Journal Articles

Frequency and Prognostic Impact of NUP98/NSD1 Translocations in Adult AML and MDS Patients

Felicitas Thol, MD, Britta Kölking, Iris H.I.M. Hollink, MD, PhD, Frederik Damm, MD, Marry M. van den Heuvel-Eibrink, C. Michel Zwaan, MD, PhD, Gesine Bug, Oliver G. Ottmann, MD, Katharina Wagner, MD, Michael A Morgan, PhD, Wolf-Karsten Hofmann, Gudrun Göhring, MD, Brigitte Schlegelberger, Jürgen Krauter, Prof. Dr. med., Arnold Ganser, Michael Heuser, MD

Blood (2012) 120 (21): 1402.

https://doi.org/10.1182/blood.V120.21.1402.1402

Published: 2012

Journal Articles

The Role of MSI2 Expression Levels on Outcome of MDS and AML Patients

Felicitas Thol, M.D., Michael Heuser, M.D., Claudia Winschel, Frederik Damm, MD, Katharina Wagner, MD, Gudrun Göhring, MD, Brigitte Schlegelberger, MD, Gesine Bug, Oliver G. Ottmann, MD, PhD, Wolf-Karsten Hofmann, MD, Jürgen Krauter, MD, Ph.D., Arnold Ganser, MD

Blood (2011) 118 (21): 1734.

https://doi.org/10.1182/blood.V118.21.1734.1734

Published: 2011

Journal Articles

Prevalence and Clinical Effect of TET2 Mutations in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Birgit Markus, MD, Felicitas Thol, M.D., Michael A Morgan, PhD, Katharina Wagner, MD, Michael Heuser, M.D., Juergen Krauter, MD, Arnold Ganser, MD, Frederik Damm, MD

Blood (2011) 118 (21): 1448.

https://doi.org/10.1182/blood.V118.21.1448.1448

Published: 2011

Journal Articles

Next Generation Sequencing for Minimal Residual Disease Monitoring in AML Patients with FLT3-ITD,

Felicitas Thol, Frederik Damm, Katharina Wagner, Katarina Reinhardt, Jan-Henning Klusmann, MD, Nils von Neuhoff, Brigitte Schlegelberger, MD, Dirk Reinhardt, MD, PhD, Jürgen Krauter, Arnold Ganser, MD, Michael Heuser, M.D.

Blood (2011) 118 (21): 3548.

https://doi.org/10.1182/blood.V118.21.3548.3548

Published: 2011

Journal Articles

ID1 Expression Correlates with CEBPA Mutational Status and Is Not An Independent Risk Factor in Cytogenetically Normal AML,

Katharina Wagner, MD, Frederik Damm, MD, Michael A Morgan, PhD, Felicitas Thol, M.D., Haiyang Yun, Gudrun Göhring, MD, Brigitte Schlegelberger, M.D., Michael Heuser, M.D., Arnold Ganser, MD, Jürgen Krauter, MD

Blood (2011) 118 (21): 3554.

https://doi.org/10.1182/blood.V118.21.3554.3554

Published: 2011

Journal Articles

Integrative prognostic risk score in acute myeloid leukemia with normal karyotype

Frederik Damm, Michael Heuser, Michael Morgan, Katharina Wagner, Kerstin Görlich, Anika Großhennig, Iyas Hamwi, Felicitas Thol, Ewa Surdziel, Walter Fiedler, Michael Lübbert, Lothar Kanz, Christoph Reuter, Gerhard Heil, Ruud Delwel, Bob Löwenberg, Peter J. M. Valk, Jürgen Krauter, Arnold Ganser

Blood (2011) 117 (17): 4561–4568.

https://doi.org/10.1182/blood-2010-08-303479

Published: 2011

Includes: Supplemental data

Journal Articles

FLT3-ITD and Age Are the Major Prognostic Factors In Relapsed AML with Normal Karyotype

Jürgen Krauter, MD, Katharina Wagner, MD, Frederik Damm, MD, Felicitas Thol, MD, Walter Fiedler, MD, Oliver G. Ottmann, MD, Wolfgang F.W. Heit, MD, Michael Lübbert, MD, Aruna Raghavachar, MD, Gudrun Göhring, MD, Michael Heuser, MD, Brigitte Schlegelberger, MD, PhD, Gerhard Heil, MD, Arnold Ganser, MD

Blood (2010) 116 (21): 1719.

https://doi.org/10.1182/blood.V116.21.1719.1719

Published: 2010

Journal Articles

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

Felicitas Thol, Frederik Damm, Katharina Wagner, Gudrun Göhring, Brigitte Schlegelberger, Dieter Hoelzer, Michael Lübbert, Wolfgang Heit, Lothar Kanz, Günter Schlimok, Aruna Raghavachar, Walter Fiedler, Hartmut Kirchner, Gerhard Heil, Michael Heuser, Jürgen Krauter, Arnold Ganser

Blood (2010) 116 (4): 614–616.

https://doi.org/10.1182/blood-2010-03-272146

Published: 2010

Includes: Supplemental data

Journal Articles

A Distal Single Nucleotide Polymorphism Disrupts Development-Dependent Long-Range Transcriptional Regulation of the PU.1 Gene through the Chromatin-Remodeling Protein SATB1 in Acute Myeloid Leukemia.

Blood (2007) 110 (11): 3175.

https://doi.org/10.1182/blood.V110.11.3175.3175

Published: 2007

Journal Articles

Prognostic Factors in Adult Patients up to 60 Years with AML and Translocations of Chromosome 11q23: Individual Patient Data Based Analysis of the German AML-Intergroup.

Jürgen Krauter, MD, Katharina Wagner, M.D., Irina Schäfer, Rolf Marschalek, Ph.D., Claus Meyer, M.D., Gerhard Heil, M.D., Markus Andreas Schaich, M.D., Gerhard Ehninger, M.D., Dietger W. Niederwieser, M.D., Rainer Krahl, M.D., Thomas Buchner, M.D., Cristina Sauerland, Brigitte Schlegelberger, M.D., Konstanze Dohner, M.D., Hartmut Dohner, M.D., Richard Schlenk, M.D., Arnold Ganser, M.D.

Blood (2007) 110 (11): 759.

https://doi.org/10.1182/blood.V110.11.759.759

Published: 2007

Journal Articles

Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the German AML-Intergroup.

Jürgen Krauter, MD, Katharina Wagner, M.D., Irina Schäfer, Rolf Marschalek, Ph.D., Claus Meyer, M.D., Gerhard Heil, M.D., Markus Andreas Schaich, M.D., Gerhard Ehninger, M.D., Dietger W. Niederwieser, M.D., Rainer Krahl, M.D., Konstanze Dohner, M.D., Hartmut Dohner, M.D., Richard Schlenk, M.D., Arnold Ganser, M.D.

Blood (2006) 108 (11): 16.

https://doi.org/10.1182/blood.V108.11.16.16

Published: 2006

Journal Articles

Essential Role of Jun Family Transcription Factors in PU.1-Induced Leukemic Stem Cell Transformation.

Ulrich Steidl, MD, PhD, Frank Rosenbauer, PhD, Roel G.W Verhaak, Xuesong Gu, PhD, Hasan H. Otu, PhD, Shakir Kolia, PhD, Bronwyn M. Owens, PhD, Steffen Klippel, PhD, Katharina Wagner, MD, Manuel Aivado, MD, Emmanuelle Passegue, PhD, Towia A. Libermann, PhD, Ruud Delwel, PhD, Daniel G. Tenen, MD

Blood (2005) 106 (11): 463.

https://doi.org/10.1182/blood.V106.11.463.463

Published: 2005

Journal Articles

Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the AML-SG and SHG-Dresden Study Groups.

Jürgen Krauter, MD, Irina Schäfer, Anke Kohlenberg, MD, Katharina Wagner, MD, Gerhard Heil, MD, Markus Schaich, MD, Gerhard Ehninger, MD, Konstanze Döhner, MD, Hartmut Döhner, MD, Richard Schlenk, MD, Arnold Ganser, MD

Blood (2005) 106 (11): 2360.

https://doi.org/10.1182/blood.V106.11.2360.2360

Published: 2005

Journal Articles

Identification of ID4 as a Cooperating Second Hit for T Cell Lymphoma Development in PU.1 URE Δ/Δ Mice.

Bronwyn M. Owens, PhD, Li Yu, PhD, Ulrich Steidl, MD, Jeffrey L. Kutok, MD, Linda K. Clayton, PhD, Katharina Wagner, MD, Hiromi Iwasaki, MD, Chunhui Liu, Björn Hackanson, MD, Koichi Akashi, MD, Christoph Plass, PhD, Daniel G. Tenen, MD, Frank Rosenbauer, PhD

Blood (2005) 106 (11): 2613.

https://doi.org/10.1182/blood.V106.11.2613.2613

Published: 2005

Journal Articles

Reduced Binding of C/EBPα to Myeloid Specific Promoters with Altered Gene Expression in the Presence of PML/RARα.

Katharina Wagner, MD, Jürgen Krauter, MD, Kerstin Görlich, Bettina Drescher, PhD, Lisa M. Johansen, PhD, Hanna S. Radomska, PhD, Estelle Duprez, PhD, Arnold Ganser, MD, Daniel G. Tenen, MD

Blood (2005) 106 (11): 2999.

https://doi.org/10.1182/blood.V106.11.2999.2999

Published: 2005

Journal Articles

Valproic Acid Induces Cell Cycle Arrest and Differentiation of t(15;17) Positive Leukemic Cells Independent from ATRA Sensitivity and Has No Effect on CD34 pos Cells.

Bettina Drescher, PhD, Kerstin Goerlich, Dagmar Reile, Axel Doehring, Arnold Ganser, MD, Gerhard Heil, MD, Katharina Wagner, MD, Juergen Krauter, MD

Blood (2005) 106 (11): 2834.

https://doi.org/10.1182/blood.V106.11.2834.2834

Published: 2005

Journal Articles

Complete Absence of the Lineage-Determining Transcription Factor C/EBPα Results in Loss of Myeloid Identity in Bcr/abl Induced Malignancy.

Katharina Wagner, MD, Pu Zhang, MD, Frank Rosenbauer, PhD, Bettina Drescher, PhD, Susumu Kobayashi, MD, Hanna S. Radomska, PhD, Jeffery L. Kutok, MD, Jürgen Krauter, MD, Daniel G. Tenen, MD

Blood (2005) 106 (11): 646.

https://doi.org/10.1182/blood.V106.11.646.646

Published: 2005

Journal Articles

Decrease of Malignant Potential of t(8;21) Positive Cells after Stable Expression of RUNX-CBFA2T1-Specific Small Interfering RNA.

Bettina Drescher, PhD, Kerstin Goerlich, Dagmar Reile, Gerhard Heil, M.D., Olaf Heidenreich, PhD, Katharina Wagner, M.D., Arnold Ganser, M.D., Juergen Krauter, M.D.

Blood (2004) 104 (11): 4274.

https://doi.org/10.1182/blood.V104.11.4274.4274

Published: 2004

NARROW

Expression Of Hedgehog Pathway Mediator Gli2 Represents a Clinically Negative Prognostic Marker In Acute Myeloid Leukemia and Its Inhibitor GANT61 Exerts Anti-Leukemic Effects In Vitro

Clinical Impact of TERT A1062T Mutations in Younger Patients with Acute Myeloblastic Leukemia

Frequency and Prognostic Impact of NUP98/NSD1 Translocations in Adult AML and MDS Patients

The Role of MSI2 Expression Levels on Outcome of MDS and AML Patients

Prevalence and Clinical Effect of TET2 Mutations in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Next Generation Sequencing for Minimal Residual Disease Monitoring in AML Patients with FLT3-ITD,

ID1 Expression Correlates with CEBPA Mutational Status and Is Not An Independent Risk Factor in Cytogenetically Normal AML,

Integrative prognostic risk score in acute myeloid leukemia with normal karyotype

FLT3-ITD and Age Are the Major Prognostic Factors In Relapsed AML with Normal Karyotype

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

A Distal Single Nucleotide Polymorphism Disrupts Development-Dependent Long-Range Transcriptional Regulation of the PU.1 Gene through the Chromatin-Remodeling Protein SATB1 in Acute Myeloid Leukemia.

Prognostic Factors in Adult Patients up to 60 Years with AML and Translocations of Chromosome 11q23: Individual Patient Data Based Analysis of the German AML-Intergroup.

Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the German AML-Intergroup.

Essential Role of Jun Family Transcription Factors in PU.1-Induced Leukemic Stem Cell Transformation.

Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the AML-SG and SHG-Dresden Study Groups.

Identification of ID4 as a Cooperating Second Hit for T Cell Lymphoma Development in PU.1 URE Δ/Δ Mice.

Reduced Binding of C/EBPα to Myeloid Specific Promoters with Altered Gene Expression in the Presence of PML/RARα.

Valproic Acid Induces Cell Cycle Arrest and Differentiation of t(15;17) Positive Leukemic Cells Independent from ATRA Sensitivity and Has No Effect on CD34 pos Cells.

Complete Absence of the Lineage-Determining Transcription Factor C/EBPα Results in Loss of Myeloid Identity in Bcr/abl Induced Malignancy.

Decrease of Malignant Potential of t(8;21) Positive Cells after Stable Expression of RUNX-CBFA2T1-Specific Small Interfering RNA.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only